SERPINF1 and neoplasm: PEDF was shown to normalise metabolic activity by reducing glycolysis reliance in both MDA-MB-231 and MCF-7 cell lines, thereby limiting lactate production and its associated tumour-promoting effects, either alone or in combination with Dox.